Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for gsk690693 (compound)
Most Correlated Studies
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
- L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
- L1000 CMAP - Breast adenocarcinoma SKBR3 cells treated with small molecule perturbagens
Most Relevant Literature
- Inhibitor GSK690693 extends Drosophila lifespan via reduce AKT signaling pathway.
- Akt dependent adult hippocampal neurogenesis regulates the behavioral improvement of treadmill runni…
- 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone-Induced Histone Acetylation via α7nAChR-Mediated PI3K…
- Discovery of 14-3-3 protein-protein interaction inhibitors that sensitize multidrug-resistant cancer…
- A screen for kinase inhibitors identifies antimicrobial imidazopyridine aminofurazans as specific in…
Most Relevant Clinical Trials
- Study to Investigate AKT Inhibitor GSK690693 in Subjects With Relapsed or Refractory Hematologic Mal…
- Open-label Study to Investigate the Safety, Tolerability, PK, and Pharmacodynamics of the AKT Inhibi…
- Testing GDC-0032 (Taselisib) as a Potential Targeted Treatment in Cancers With PIK3CA Genetic Change…
